BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18780836)

  • 1. hem6: an ENU-induced recessive hypochromic microcytic anemia mutation in the mouse.
    Tian M; Campagna DR; Woodward LS; Justice MJ; Fleming MD
    Blood; 2008 Nov; 112(10):4308-13. PubMed ID: 18780836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
    Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
    Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse.
    Ohgami RS; Campagna DR; Antiochos B; Wood EB; Sharp JJ; Barker JE; Fleming MD
    Blood; 2005 Nov; 106(10):3625-31. PubMed ID: 15994289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
    Barman-Aksözen J; Halloy F; Iyer PS; Schümperli D; Minder AE; Hall J; Minder EI; Schneider-Yin X
    Mol Genet Metab; 2019 Nov; 128(3):304-308. PubMed ID: 31076252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.
    Iolascon A; De Falco L; Beaumont C
    Haematologica; 2009 Mar; 94(3):395-408. PubMed ID: 19181781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).
    Bishop DF; Tchaikovskii V; Hoffbrand AV; Fraser ME; Margolis S
    J Biol Chem; 2012 Aug; 287(34):28943-55. PubMed ID: 22740690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferrochelatase deficiency in the bone marrow in a syndrome of congenital hypochromic microcytic anemia, hyperferremia, and iron overload of the liver.
    Stavem P; Romslo I; Hovig T; Rootwelt K; Emblem R
    Scand J Gastroenterol Suppl; 1985; 107():73-81. PubMed ID: 3856939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.
    Blouin JM; Ged C; Lalanne M; Lamrissi-Garcia I; Morice-Picard F; Costet P; Daher R; Moreau-Gaudry F; Bedel A; Puy H; Gouya L; Karim Z; Richard E
    Blood; 2020 Nov; 136(21):2457-2468. PubMed ID: 32678895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
    To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
    Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
    Cooperman SS; Meyron-Holtz EG; Olivierre-Wilson H; Ghosh MC; McConnell JP; Rouault TA
    Blood; 2005 Aug; 106(3):1084-91. PubMed ID: 15831703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inheritance in erythropoietic protoporphyria].
    Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
    Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
    Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.
    Balwani M
    Mol Genet Metab; 2019 Nov; 128(3):298-303. PubMed ID: 30704898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis.
    Sadlon TJ; Dell'Oso T; Surinya KH; May BK
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1153-67. PubMed ID: 10582344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release.
    Fratz EJ; Clayton J; Hunter GA; Ducamp S; Breydo L; Uversky VN; Deybach JC; Gouya L; Puy H; Ferreira GC
    Biochemistry; 2015 Sep; 54(36):5617-31. PubMed ID: 26300302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
    Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
    Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP).
    Ducamp S; Schneider-Yin X; de Rooij F; Clayton J; Fratz EJ; Rudd A; Ostapowicz G; Varigos G; Lefebvre T; Deybach JC; Gouya L; Wilson P; Ferreira GC; Minder EI; Puy H
    Hum Mol Genet; 2013 Apr; 22(7):1280-8. PubMed ID: 23263862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular genetics of erythropoietic protoporphyria.
    Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron distribution in Belgrade rat reticulocytes after inhibition of heme synthesis with succinylacetone.
    Garrick LM; Gniecko K; Liu Y; Cohan DS; Grasso JA; Garrick MD
    Blood; 1993 Jun; 81(12):3414-21. PubMed ID: 8507877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
    Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
    JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.